Xin Li

Associate Professor, Department of Urology

Keywords
prostate cancer, bone metabolism, diabetes
Summary

The research projects in our laboratory are centered on the mechanisms of action of metformin, the most prescribed anti–type II diabetes medicine. We are particularly interested in its antineoplastic effects and its impact on bone metabolism in diabetes.

Using various animal and cell culture models and molecular and cellular techniques, we have revealed the role of metformin as an epigenetic regulator and metabolic rebalancer, restoring normal cellular function in cancer and diabetes.

Phone

212-992-7009

Fax

212-995-4085

Academic office

345 East 24th Street, 901D

New York, NY 10010

Is this your profile?
Edit profile

These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Positions

Associate Professor, Department of Urology at NYU Grossman School of Medicine

Postdoctoral Training

University of Michigan, Laurie McCauley

The influence of the gut microbiota on B cells in autoimmune diseases

He, Lun; Li, Xin; Jiang, Shan; Ou, Yanhua; Wang, Shanshan; Shi, Na; Yang, Zhongshan; Yuan, Jia-Li; Silverman, Gregg; Niu, Haitao

Molecular medicine (Cambridge, Mass.). 2025 Apr 22; 31(1):149

Ultrasound-Induced Synchronized Neural Activities at 40 Hz and 200 Hz Entrained Corresponded Oscillations and Improve Alzheimer's Disease Memory

Chen, Jiamin; Wang, Xingran; Li, Xin; Li, Xiaoli; Zhang, Yiyao; Yuan, Yi

CNS neuroscience & therapeutics. 2025 Apr; 31(4):e70351

The impact of aging on neutrophil functions and the contribution to periodontitis

Wang, Zi; Saxena, Anish; Yan, Wenbo; Uriarte, Silvia M; Siqueira, Rafael; Li, Xin

International journal of oral science. 2025 Jan 16; 17(1):10

Role of Fungi in Tumorigenesis: Promises and Challenges

Guglietta, Silvia; Li, Xin; Saxena, Deepak

Annual review of pathology. 2025 Jan; 20(1):459-482

A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus

Pothuri, B; Sawaged, Z; Karpel, H C; Li, X; Lee, J; Musa, F; Lutz, K; Reese, E; Blank, S V; Boyd, L R; Curtin, J P; Goldberg, J D; Muggia, F M

Gynecologic oncology. 2024 Sep 03; 190:209-214

Application of the Six-Minute Walk Test in Assessment of the Cardiopulmonary Function of Children With Idiopathic Scoliosis

Guo, Haibin; Zhou, Xuan; Li, Yanyan; Yang, Yuqi; Yu, Hong; Li, Xin; Yuan, Haiyan; Chen, Yushan; Feng, Yufei; Huang, Jiaoling; Du, Qing

Spine. 2024 Jun 15; 49(12):840-846

A novel SUCNR1 inhibitor alleviates dysbiosis through inhibition of host responses without direct interaction with host microbiota

Thomas, Scott C; Guo, Yuqi; Xu, Fangxi; Saxena, Deepak; Li, Xin

Molecular oral microbiology. 2024 Apr; 39(2):80-90

Getting off tract: contributions of intraorgan microbiota to cancer in extraintestinal organs

Thomas, Scott C; Miller, George; Li, Xin; Saxena, Deepak

Gut. 2023 Dec 07; 73(1):175-185

See All Publications (107)